Protection effect of Zhen-Wu-Tang on adriamycin-induced nephrotic syndrome via inhibiting oxidative lesions and inflammation damage

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Liang, Chun Ling ^a   Wu, Jun Biao ^a   Lai, Jie Mei ^a   Ye, Shu Fang ^a   Lin, Jin ^a   Ouyang, Hui ^a   Zhan, Janis Ya Xian ^a   Zhou, Jiu Yao ^a  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIOXIDANT; CHINESE DRUG; CHOLESTEROL; CREATININE; DOXORUBICIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 4; INTERLEUKIN 8; MALONALDEHYDE; MESSENGER RNA; PAEONIA RADIX; PROTEIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UREA; ZHEN WU TANG;

ACONITUM CARMICHAELII; ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ELECTRON MICROSCOPY; GINGER; GLOMERULAR STRUCTURE; GLOMERULUS; HISTOPATHOLOGY; MALE; MICROSCOPY; NEPHROTIC SYNDROME; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RAT; RENAL PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UREA NITROGEN BLOOD LEVEL;

EID: 84900300159     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/131604     Document Type: Article

References (47)

1. Horvath M., Sulyok E., Steroid responsive nephrotic syndrome in Asians. Archives of Disease in Childhood 1986 61 5 528 2-s2.0-0022708672
2. Eckardt K. U., Coresh J., Devuyst O., Evolving importance of kidney disease: from subspecialty to global health burden. The Lancet 2013 382 9887 158 169 10.1016/S0140-6736(13)60439-0
3. Lewis J. B., Neilson E. G., Haerison's Nephrology and Acid-Base Disorders 2011 Beijing, China Peking University Medical Press
4. Shalhoub R. J., Pathogenesis of lipoid nephrosis: a disorder of T cell function. The Lancet 1974 2 7880 556 560 2-s2.0-0016266173
5. Shalaby S. A., Al-Edressi H. M., El-Tarhouny S. A., Fath El-Bab M., Zolaly M. A., Type 1/type 2 cytokine serum levels and role of interleukin-18 in children with steroid-sensitive nephrotic syndrome. Arab Journal of Nephrology and Transplantation 2013 6 2 83 88
6. Couser W. G., Basic and translational concepts of immune-mediated glomerular diseases. Journal of the American Society of Nephrology 2012 23 3 381 399 2-s2.0-84857953534 10.1681/ASN.2011030304
7. Zoja C., Garcia P. B., Remuzzi G., The role of chemokines in progressive renal disease. Frontiers in Bioscience 2009 14 5 1815 1822 2-s2.0-63849087686 10.2741/3343
8. Kim K.-H., Lee E.-S., Cha S.-H., Park J.-H., Park J.-S., Chang Y.-C., Park K.-K., Transcriptional regulation of NF- B by ring type decoy oligodeoxynucleotide in an animal model of nephropathy. Experimental and Molecular Pathology 2009 86 2 114 120 2-s2.0-63149162780 10.1016/j.yexmp.2008. 11.011
9. Audard V., Pawlak A., Candelier M., Lang P., Sahali D., Upregulation of nuclear factor-related kappa b suggests a disorder of transcriptional regulation in minimal change nephrotic syndrome. PLoS ONE 2012 7 1 2-s2.0-84856088656 10.1371/journal.pone.0030523 e30523
10. Fujihara C. K., Antunes G. R., Mattar A. L., Malheiros D. M. A. C., Vieira J. M. Jr., Zatz R., Chronic inhibition of nuclear factor- B attenuates renal injury in the 5/6 renal ablation model. The American Journal of Physiology: Renal Physiology 2007 292 1 F92 F99 2-s2.0-33846206479 10.1152/ajprenal.00184.2006 (Pubitemid 46105247)
11. Simic I., Tabatabaeifar M., Schaefer F., Animal models of nephrotic syndrome. Pediatric Nephrology 2012 28 11 2079 2088
12. Li M., Qureshi A. R., Ellis E., Axelsson J., Impaired postprandial fibroblast growth factor (FGF)-19 response in patients with stage 5 chronic kidney diseases is ameliorated following antioxidative therapy. Nephrology Dialysis Transplantation 2013 28, supplement 4 212 219 10.1093/ndt/gft337
13. Hamada A., Yoshioka S., Takuma D., Yokota J., Cui T., Kusunose M., Miyamura M., Kyotani S., Nishioka Y., The effect of Eriobotrya japonica seed extract on oxidative stress in adriamycin-induced nephropathy in rats. Biological and Pharmaceutical Bulletin 2004 27 12 1961 1964 2-s2.0-21644459583 10.1248/bpb.27.1961 (Pubitemid 41701571)
14. Hou Z. H., Hou Z. H., Prescription and syndrome analysis of Zhenwu Decoction in Treaties of Febrile Diseases. China's Traditional Chinese Medicine Emergency 2010 3 19 48
15. Krishnan R. G., Nephrotic syndrome. Paediatrics and Child Health 2012 22 8 337 340 10.1016/j.paed.2012.02.004
16. Cai Y., Chen J., Jiang J., Cao W., He L., Zhen-wu-tang, a blended traditional Chinese herbal medicine, ameliorates proteinuria and renal damage of streptozotocin-induced diabetic nephropathy in rats. Journal of Ethnopharmacology 2010 131 1 88 94 2-s2.0-77955314144 10.1016/j.jep.2010.06.004
17. Geng G J., Wang C. S., Gu W. B., The effects of Zhenwu Decoction on the extracellular matrix of rat mesangial cells. Journal of Traditional Chinese Medicine 2000 41 11 686 687
18. Kaneko Y., Narita I., Nephritis and nephrotic syndrome. Nihon Jinzo Gakkai Shi 2013 55 1 35 41
19. Li D., Ding J., Molecular mechanism of proteinuria caused progression of chronic renal disease. Journal of Peking University: Health Sciences 2010 42 5 608 611 2-s2.0-80053214431
20. Kriz W., Elger M., Nagata M., Kretzler M., Uiker S., Koeppen-Hagemann I., Tenschert S., Lemley K. V., The role of podocytes in the development of glomerular sclerosis. Kidney International, Supplement 1994 45 S64 S72 2-s2.0-0003104549
21. Reiser J., Sever S., Podocyte biology and pathogenesis of kidney disease. Annual Review of Medicine 2013 64 357 366 10.1146/annurev-med-050311-163340
22. Kriz W., Podocyte is the major culprit accounting for the progression of chronic renal disease. Microscopy Research and Technique 2002 57 4 189 195 2-s2.0-0037093320 10.1002/jemt.10072 (Pubitemid 34553247)
23. Singh K., Ray R., Sharma A., Gupta R., Bagga A., Dinda A. K., Peritubular capillaries and renal function in pediatric idiopathic nephrotic syndrome. Saudi Journal of Kidney Diseases and Transplantation 2013 24 5 942 949 10.4103/1319-2442.118091
24. Hosten A. O., Walker H. K., Hall W. D., Hurst J. W., BUN and creatinine. Clinical Methods: The History, Physical, and Laboratory Examinations 1990 Boston, Mass, USA Butterworths Butterworth: A Division of Reed
25. Nakhoul F., Ramadan R., Khankin E., Yaccob A., Kositch Z., Lewin M., Assady S., Abassi Z., Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies. The American Journal of Physiology: Renal Physiology 2005 289 4 F880 F890 2-s2.0-24944555689 10.1152/ajprenal.00451.2004 (Pubitemid 41324209)
26. Hutchison F. N., Proteinuria, hyperlipidemia, and the kidney. Mineral and Electrolyte Metabolism 1993 19 3 127 136 2-s2.0-0027360506 (Pubitemid 23305539)
27. Mathieson P. W., Immune dysregulation in minimal change nephropathy. Nephrology Dialysis Transplantation 2003 18, supplement 6 vi26 vi29 2-s2.0-0041829301 (Pubitemid 37098590)
28. Eddy A. A., Symons J. M., Nephrotic syndrome in childhood. The Lancet 2003 362 9384 629 639 2-s2.0-0042466540 10.1016/S0140-6736(03)14184-0 (Pubitemid 37013306)
29. Qi Y., Xiao H., Xu C., Tian X., Wu H., Shen W., Cyprinus carpio decoction improves nutrition and immunity and reduces proteinuria through nephrin and CD2AP expressions in rats with adriamycin-induced nephropathy. Evidence-Based Complementary and Alternative Medicine 2012 2012 8 237482 10.1155/2012/237482
30. van den Berg J. G., Aten J., Chand M. A., Claessen N., Dijkink L., Wijdenes J., Lakkis F. G., Weening J. J., Interleukin-4 and interleukin-13 act on glomerular visceral epithelial cells. Journal of the American Society of Nephrology 2000 11 3 413 422 2-s2.0-0034049304 (Pubitemid 30115071)
31. Daniel V., Trautmann Y., Konrad M., Nayir A., Schårer K., T-lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome. Clinical Nephrology 1997 47 5 289 297 2-s2.0-0030918249 (Pubitemid 27230625)
32. Klementiev B., Enevoldsen M. N., Li S., Antiinflammatory properties of a peptide derived from interleukin-4. Cytokine 2013 64 1 112 121 10.1016/j.cyto.2013.07.016
33. Hart P. H., Vitti G. F., Burgess D. R., Whitty G. A., Piccoli D. S., Hamilton J. A., Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor α interleukin 1, and prostagandin E2. Proceedings of the National Academy of Sciences of the United States of America 1989 86 10 3803 3807 2-s2.0-0000999931 (Pubitemid 19141833)
34. Harris P. R., Weber H. C., Wilcox C. M., Jensen R. T., Smith P. D., Cytokine gene profile in gastric mucosa in Helicobacter pylori infection and Zollinger-Ellison syndrome. The American Journal of Gastroenterology 2002 97 2 312 318 2-s2.0-0036177082 10.1016/S0002-9270(01)04025-4 (Pubitemid 34160755)
35. Huang F., Horikoshi S., Kurusu A., Urinary levels of interleukin-8 (IL-8) and disease activity in patients with IgA nephropathy. Journal of Clinical Laboratory Analysis 2001 15 1 30 34 10.1002/1098-2825(2001)15:1<30::AID- JCLA6>3.0.CO;2-X
36. Garin E. H., Blanchard D. K., Matsushima K., Djeu J. Y., IL-8 production by peripheral blood mononuclear cells in nephrotic patients. Kidney International 1994 45 5 1311 1317 2-s2.0-0028297073 (Pubitemid 24135015)
37. Noris M., Remuzzi G., Overview of complement activation and regulation. Seminars in Nephrology 2013 33 6 479 492 10.1016/j.semnephrol.2013.08.001
38. Hayden M. S., Ghosh S., Signaling to NF- B. Genes and Development 2004 18 18 2195 2224 2-s2.0-4444376712 10.1101/gad.1228704 (Pubitemid 39209568)
39. + T-cell subsets. Immunological Reviews 2013 252 1 41 51 10.1111/imr.12033
40. Turner M. D., Chaudhry A., Nedjai B., Tumour necrosis factor receptor trafficking dysfunction opens the TRAPS door to pro-inflammatory cytokine secretion. Bioscience Reports 2012 32 2 105 112 2-s2.0-84856927035 10.1042/BSR20110089
41. Viatour P., Merville M.-P., Bours V., Chariot A., Phosphorylation of NF- B and I B proteins: implications in cancer and inflammation. Trends in Biochemical Sciences 2005 30 1 43 52 2-s2.0-11844269840 10.1016/j.tibs.2004.11. 009 (Pubitemid 40093740)
42. Ece A., Atamer Y., Gürkan F., Bilici M., Koçyit Y., Anti-oxidant status in relation to lipoproteins, leptin and pro-inflammatory cytokines in children with steroid-sensitive nephrotic syndrome. Nephrology 2004 9 6 366 373 2-s2.0-12244257550 10.1111/j.1440-1797.2004.00340.x (Pubitemid 40115961)
43. Mathew J. L., Kabi B. C., Rath B., Anti-oxidant vitamins and steroid responsive nephrotic syndrome in Indian children. Journal of Paediatrics and Child Health 2002 38 5 450 454 2-s2.0-0036407419 10.1046/j.1440-1754.2002.00016. x (Pubitemid 35217526)
44. Small D. M., Coombes J. S., Bennett N., Johnson D. W., Gobe G. C., Oxidative stress, anti-oxidant therapies and chronic kidney disease. Nephrology 2012 17 4 311 321 2-s2.0-84860133754 10.1111/j.1440-1797.2012.01572.x
45. Atamer A., Kocyigit Y., Ecder S. A., Selek S., Ilhan N., Ecder T., Atamer Y., Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease. Journal of Nephrology 2008 21 6 924 930 2-s2.0-62749156511
46. Mishra O. P., Gupta A. K., Prasad R., Ali Z., Upadhyay R. S., Mishra S. P., Tiwary N. K., Schaefer F. S., Antioxidant status of children with idiopathic nephrotic syndrome. Pediatric Nephrology 2011 26 2 251 256 2-s2.0-78751582308 10.1007/s00467-010-1696-6
47. Ghodake S. R., Suryakar A. N., Ankush R. D., Katkam R. V., Shaikh K., Katta A. V., Role of free radicals and antioxidant status in childhood nephrotic syndrome. Indian Journal of Nephrology 2011 21 1 37 40 2-s2.0-79953793404 10.4103/0971-4065.78062